iCAD Leadership in Breast Health AI Showcased at ECR 2025
iCAD is capitalizing on 20+ years of innovation in breast health AI. As the first to bring AI-powered DBT detection to market, iCAD continues to lead the way with wide-ranging AI solutions, cloud-enabled connectivity, and next generation algorithms that are transforming patient care and breast health for the future, including...
At ECR 2024, iCAD showed strong collaboration at European Congress: A Recap of Key Events
At this year’s European Congress of Radiology (ECR 2024) in Vienna, Austria, iCAD demonstrated how the ProFound AI Breast Health Suite enables medical providers to detect cancer earlier and more accurately, improving patient outcomes. The demonstrations highlighted the new release of its AI-powered ProFound Detection workflow solution, while showcasing its...